{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "", "tokens": ["Introduction"], "sentence": "Introduction", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "", "tokens": ["Epstein-Barr", "virus", "(", "EBV", ")", "is", "a", "ubiquitous", "gamma-herpesvirus", "that", "infects", "humans", "predominantly", "at", "an", "early", "age", "with", "greater", "than", "90", "%", "of", "the", "adult", "population", "infected", "with", "EBV", "[", "1", "]", "."], "sentence": "Epstein-Barr virus ( EBV ) is a ubiquitous gamma-herpesvirus that infects humans predominantly at an early age with greater than 90 % of the adult population infected with EBV [ 1 ] .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "", "tokens": ["EBV", "is", "linked", "to", "the", "development", "of", "both", "B", "lymphocyte", "and", "epithelial", "cell", "malignancies", ",", "including", "Burkitt", "lymphoma", ",", "Hodgkin", "disease", "(", "HD", ")", ",", "and", "nasopharyngeal", "carcinoma", "(", "NPC", ")", ",", "and", "cancers", "linked", "to", "immunosuppression", ",", "including", "post-transplant", "lymphoma", "and", "AIDS", "-", "associated", "lymphomas", "[", "2", ",", "3", "]", "."], "sentence": "EBV is linked to the development of both B lymphocyte and epithelial cell malignancies , including Burkitt lymphoma , Hodgkin disease ( HD ) , and nasopharyngeal carcinoma ( NPC ) , and cancers linked to immunosuppression , including post-transplant lymphoma and AIDS - associated lymphomas [ 2 , 3 ] .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "", "tokens": ["In", "vitro", "infection", "of", "B", "lymphocytes", "with", "EBV", "induces", "permanent", "growth", "transformation", ",", "and", "this", "ability", "to", "affect", "cell", "growth", "regulation", "likely", "contributes", "to", "the", "development", "of", "cancer", "."], "sentence": "In vitro infection of B lymphocytes with EBV induces permanent growth transformation , and this ability to affect cell growth regulation likely contributes to the development of cancer .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "", "tokens": ["Many", "of", "the", "viral", "proteins", "expressed", "in", "transformed", "cells", ",", "including", "the", "EBV", "nuclear", "antigens", "and", "latent", "membrane", "proteins", ",", "have", "profound", "effects", "on", "cell", "growth", "regulation", "and", "are", "required", "for", "EBV", "latent", "infection", "and", "B", "cell", "transformation", "[", "1", "]", "."], "sentence": "Many of the viral proteins expressed in transformed cells , including the EBV nuclear antigens and latent membrane proteins , have profound effects on cell growth regulation and are required for EBV latent infection and B cell transformation [ 1 ] .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "S6", "tokens": ["Latent", "membrane", "protein", "1", "(", "LMP1", ")", "is", "considered", "the", "major", "oncoprotein", "of", "EBV", ",", "as", "it", "transforms", "rodent", "fibroblasts", "to", "tumorigenicity", "in", "nude", "mice", "and", "is", "expressed", "in", "HD", ",", "NPC", ",", "and", "immunosuppression", "-", "associated", "tumors", "[", "4-8", "]", "."], "sentence": "Latent membrane protein 1 ( LMP1 ) is considered the major oncoprotein of EBV , as it transforms rodent fibroblasts to tumorigenicity in nude mice and is expressed in HD , NPC , and immunosuppression - associated tumors [ 4-8 ] .", "event_mentions": [{"id": "E1", "event_type": "Gene_expression", "trigger": {"text": "expressed", "start": 27, "end": 27}, "arguments": [{"entity_id": "T1", "text": "Latent membrane protein 1", "role": "Theme"}]}], "entity_mentions": [{"id": "T1", "text": "Latent membrane protein 1", "entity_type": "Protein", "start": 0, "end": 3}, {"id": "T2", "text": "LMP1", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T58", "text": "expressed", "entity_type": "Gene_expression", "start": 27, "end": 27}]}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "S7", "tokens": ["In", "B", "lymphocytes", ",", "LMP1", "mimics", "CD40", "signaling", ",", "and", "both", "LMP1", "and", "CD40", "are", "essential", "for", "EBV", "-", "mediated", "B", "cell", "transformation", "[", "9-11", "]", "."], "sentence": "In B lymphocytes , LMP1 mimics CD40 signaling , and both LMP1 and CD40 are essential for EBV - mediated B cell transformation [ 9-11 ] .", "event_mentions": [], "entity_mentions": [{"id": "T3", "text": "LMP1", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T4", "text": "CD40", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T5", "text": "LMP1", "entity_type": "Protein", "start": 11, "end": 11}, {"id": "T6", "text": "CD40", "entity_type": "Protein", "start": 13, "end": 13}]}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "S8", "tokens": ["While", "CD40", "interacts", "with", "CD40", "ligand", "expressed", "on", "activated", "T", "cells", "to", "induce", "B", "cell", "activation", "and", "differentiation", ",", "LMP1", "acts", "as", "a", "constitutive", "signal", "through", "ligand", "-", "independent", "oligomerization", "."], "sentence": "While CD40 interacts with CD40 ligand expressed on activated T cells to induce B cell activation and differentiation , LMP1 acts as a constitutive signal through ligand - independent oligomerization .", "event_mentions": [{"id": "E2", "event_type": "Binding", "trigger": {"text": "interacts", "start": 2, "end": 2}, "arguments": [{"entity_id": "T7", "text": "CD40", "role": "Theme"}, {"entity_id": "T8", "text": "CD40 ligand", "role": "Theme"}]}, {"id": "E3", "event_type": "Gene_expression", "trigger": {"text": "expressed", "start": 6, "end": 6}, "arguments": [{"entity_id": "T8", "text": "CD40 ligand", "role": "Theme"}]}, {"id": "E4", "event_type": "Binding", "trigger": {"text": "oligomerization", "start": 29, "end": 29}, "arguments": [{"entity_id": "T9", "text": "LMP1", "role": "Theme"}]}], "entity_mentions": [{"id": "T7", "text": "CD40", "entity_type": "Protein", "start": 1, "end": 1}, {"id": "T8", "text": "CD40 ligand", "entity_type": "Protein", "start": 4, "end": 5}, {"id": "T9", "text": "LMP1", "entity_type": "Protein", "start": 19, "end": 19}, {"id": "T59", "text": "interacts", "entity_type": "Binding", "start": 2, "end": 2}, {"id": "T60", "text": "expressed", "entity_type": "Gene_expression", "start": 6, "end": 6}, {"id": "T61", "text": "oligomerization", "entity_type": "Binding", "start": 29, "end": 29}]}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "S9", "tokens": ["LMP1", "and", "CD40", "interact", "with", "the", "same", "tumor", "necrosis", "factor", "receptor", "-", "associated", "factors", "(", "TRAFs", ")", "leading", "to", "activation", "of", "NFkappaB", ",", "c-Jun", "N", "terminal", "kinase", "(", "JNK", ")", ",", "and", "p38", "MAPK", "signaling", "pathways", "[", "12-16", "]", "."], "sentence": "LMP1 and CD40 interact with the same tumor necrosis factor receptor - associated factors ( TRAFs ) leading to activation of NFkappaB , c-Jun N terminal kinase ( JNK ) , and p38 MAPK signaling pathways [ 12-16 ] .", "event_mentions": [{"id": "E5", "event_type": "Binding", "trigger": {"text": "interact", "start": 3, "end": 3}, "arguments": [{"entity_id": "T10", "text": "LMP1", "role": "Theme"}]}, {"id": "E6", "event_type": "Binding", "trigger": {"text": "interact", "start": 3, "end": 3}, "arguments": [{"entity_id": "T11", "text": "CD40", "role": "Theme"}]}], "entity_mentions": [{"id": "T10", "text": "LMP1", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T11", "text": "CD40", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T12", "text": "tumor necrosis factor", "entity_type": "Protein", "start": 7, "end": 9}, {"id": "T13", "text": "c-Jun", "entity_type": "Protein", "start": 23, "end": 23}, {"id": "T62", "text": "interact", "entity_type": "Binding", "start": 3, "end": 3}]}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "", "tokens": ["Activation", "of", "NFkappaB", "is", "required", "for", "EBV", "-", "induced", "B", "cell", "transformation", "and", "its", "inhibition", "rapidly", "results", "in", "cell", "death", "[", "17", ",", "18", "]", "."], "sentence": "Activation of NFkappaB is required for EBV - induced B cell transformation and its inhibition rapidly results in cell death [ 17 , 18 ] .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "S11", "tokens": ["Recent", "studies", "indicate", "that", "LMP1", "also", "activates", "phosphatidylinositol", "3", "kinase", "(", "PI3K", ")", "/", "Akt", "signaling", "and", "that", "this", "activation", "is", "required", "for", "LMP1", "-", "mediated", "transformation", "of", "rodent", "fibroblasts", "[", "5", ",", "19", "]", "."], "sentence": "Recent studies indicate that LMP1 also activates phosphatidylinositol 3 kinase ( PI3K ) / Akt signaling and that this activation is required for LMP1 - mediated transformation of rodent fibroblasts [ 5 , 19 ] .", "event_mentions": [], "entity_mentions": [{"id": "T14", "text": "LMP1", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T15", "text": "Akt", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T16", "text": "LMP1", "entity_type": "Protein", "start": 23, "end": 23}]}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "S12", "tokens": ["In", "vitro", ",", "primary", "B", "cells", "can", "be", "maintained", "by", "CD40", "ligation", "in", "combination", "with", "IL4", "treatment", "."], "sentence": "In vitro , primary B cells can be maintained by CD40 ligation in combination with IL4 treatment .", "event_mentions": [{"id": "E7", "event_type": "Binding", "trigger": {"text": "ligation", "start": 11, "end": 11}, "arguments": [{"entity_id": "T17", "text": "CD40", "role": "Theme"}]}], "entity_mentions": [{"id": "T17", "text": "CD40", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T18", "text": "IL4", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T63", "text": "ligation", "entity_type": "Binding", "start": 11, "end": 11}]}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "S13", "tokens": ["In", "vivo", ",", "CD40", "signaling", "is", "necessary", "for", "germinal", "center", "(", "GC", ")", "formation", "such", "that", "mice", "deficient", "for", "CD40", "or", "CD40L", "are", "unable", "to", "form", "GCs", "in", "response", "to", "T", "cell", "-", "dependent", "antigens", "[", "20", ",", "21", "]", "."], "sentence": "In vivo , CD40 signaling is necessary for germinal center ( GC ) formation such that mice deficient for CD40 or CD40L are unable to form GCs in response to T cell - dependent antigens [ 20 , 21 ] .", "event_mentions": [{"id": "E8", "event_type": "Negative_regulation", "trigger": {"text": "deficient", "start": 17, "end": 17}, "arguments": [{"entity_id": "T20", "text": "CD40", "role": "Theme"}]}, {"id": "E9", "event_type": "Negative_regulation", "trigger": {"text": "deficient", "start": 17, "end": 17}, "arguments": [{"entity_id": "T21", "text": "CD40L", "role": "Theme"}]}], "entity_mentions": [{"id": "T19", "text": "CD40", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T20", "text": "CD40", "entity_type": "Protein", "start": 19, "end": 19}, {"id": "T21", "text": "CD40L", "entity_type": "Protein", "start": 21, "end": 21}, {"id": "T64", "text": "deficient", "entity_type": "Negative_regulation", "start": 17, "end": 17}]}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "S14", "tokens": ["Both", "the", "membrane", "proximal", "and", "distal", "cytoplasmic", "regions", "of", "CD40", "that", "bind", "TRAF6", "and", "TRAFs2", "/", "3", "/", "5", ",", "respectively", ",", "are", "necessary", "for", "GC", "formation", ",", "but", "either", "region", "is", "sufficient", "to", "induce", "extrafollicular", "B", "cell", "differentiation", "and", "restore", "low", "affinity", "antibody", "production", "[", "22", "]", "."], "sentence": "Both the membrane proximal and distal cytoplasmic regions of CD40 that bind TRAF6 and TRAFs2 / 3 / 5 , respectively , are necessary for GC formation , but either region is sufficient to induce extrafollicular B cell differentiation and restore low affinity antibody production [ 22 ] .", "event_mentions": [{"id": "E10", "event_type": "Binding", "trigger": {"text": "bind", "start": 11, "end": 11}, "arguments": [{"entity_id": "T22", "text": "CD40", "role": "Theme"}, {"entity_id": "T23", "text": "TRAF6", "role": "Theme"}]}, {"id": "E11", "event_type": "Binding", "trigger": {"text": "bind", "start": 11, "end": 11}, "arguments": [{"entity_id": "T22", "text": "CD40", "role": "Theme"}, {"entity_id": "T24", "text": "TRAFs2", "role": "Theme"}]}, {"id": "E12", "event_type": "Binding", "trigger": {"text": "bind", "start": 11, "end": 11}, "arguments": [{"entity_id": "T22", "text": "CD40", "role": "Theme"}, {"entity_id": "T25", "text": "3", "role": "Theme"}]}, {"id": "E13", "event_type": "Binding", "trigger": {"text": "bind", "start": 11, "end": 11}, "arguments": [{"entity_id": "T22", "text": "CD40", "role": "Theme"}, {"entity_id": "T26", "text": "5", "role": "Theme"}]}], "entity_mentions": [{"id": "T22", "text": "CD40", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T23", "text": "TRAF6", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T24", "text": "TRAFs2", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T25", "text": "3", "entity_type": "Protein", "start": 16, "end": 16}, {"id": "T26", "text": "5", "entity_type": "Protein", "start": 18, "end": 18}, {"id": "T67", "text": "bind", "entity_type": "Binding", "start": 11, "end": 11}]}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "S15", "tokens": ["Functionally", ",", "LMP1", "can", "rescue", "CD40", "-", "deficient", "mice", "and", "restore", "immunoglobulin", "(", "Ig", ")", "class", "switching", ",", "most", "likely", "because", "LMP1", "recruits", "similar", "TRAF", "molecules", ",", "TRAFs", "1", "/", "2", "/", "3", "/", "5", "and", "TRAF6", ",", "through", "the", "C-terminal", "activation", "regions", "1", "and", "2", "domains", ",", "respectively", "."], "sentence": "Functionally , LMP1 can rescue CD40 - deficient mice and restore immunoglobulin ( Ig ) class switching , most likely because LMP1 recruits similar TRAF molecules , TRAFs 1 / 2 / 3 / 5 and TRAF6 , through the C-terminal activation regions 1 and 2 domains , respectively .", "event_mentions": [{"id": "E14", "event_type": "Negative_regulation", "trigger": {"text": "rescue", "start": 4, "end": 4}, "arguments": [{"entity_id": "T69", "text": "deficient", "role": "Theme"}]}, {"id": "E15", "event_type": "Negative_regulation", "trigger": {"text": "deficient", "start": 7, "end": 7}, "arguments": [{"entity_id": "T28", "text": "CD40", "role": "Theme"}]}, {"id": "E16", "event_type": "Binding", "trigger": {"text": "recruits", "start": 22, "end": 22}, "arguments": [{"entity_id": "T29", "text": "LMP1", "role": "Theme"}, {"entity_id": "T30", "text": "TRAFs 1", "role": "Theme"}]}, {"id": "E17", "event_type": "Binding", "trigger": {"text": "recruits", "start": 22, "end": 22}, "arguments": [{"entity_id": "T29", "text": "LMP1", "role": "Theme"}, {"entity_id": "T31", "text": "2", "role": "Theme"}]}, {"id": "E18", "event_type": "Binding", "trigger": {"text": "recruits", "start": 22, "end": 22}, "arguments": [{"entity_id": "T29", "text": "LMP1", "role": "Theme"}, {"entity_id": "T32", "text": "3", "role": "Theme"}]}, {"id": "E19", "event_type": "Binding", "trigger": {"text": "recruits", "start": 22, "end": 22}, "arguments": [{"entity_id": "T29", "text": "LMP1", "role": "Theme"}, {"entity_id": "T33", "text": "5", "role": "Theme"}]}, {"id": "E20", "event_type": "Binding", "trigger": {"text": "recruits", "start": 22, "end": 22}, "arguments": [{"entity_id": "T29", "text": "LMP1", "role": "Theme"}, {"entity_id": "T34", "text": "TRAF6", "role": "Theme"}]}], "entity_mentions": [{"id": "T27", "text": "LMP1", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T28", "text": "CD40", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T29", "text": "LMP1", "entity_type": "Protein", "start": 21, "end": 21}, {"id": "T30", "text": "TRAFs 1", "entity_type": "Protein", "start": 27, "end": 28}, {"id": "T31", "text": "2", "entity_type": "Protein", "start": 30, "end": 30}, {"id": "T32", "text": "3", "entity_type": "Protein", "start": 32, "end": 32}, {"id": "T33", "text": "5", "entity_type": "Protein", "start": 34, "end": 34}, {"id": "T34", "text": "TRAF6", "entity_type": "Protein", "start": 36, "end": 36}, {"id": "T68", "text": "rescue", "entity_type": "Negative_regulation", "start": 4, "end": 4}, {"id": "T69", "text": "deficient", "entity_type": "Negative_regulation", "start": 7, "end": 7}, {"id": "T70", "text": "recruits", "entity_type": "Binding", "start": 22, "end": 22}]}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "S16", "tokens": ["However", ",", "LMP1", "is", "unable", "to", "restore", "affinity", "maturation", "and", "GC", "formation", "[", "23", "]", "."], "sentence": "However , LMP1 is unable to restore affinity maturation and GC formation [ 23 ] .", "event_mentions": [], "entity_mentions": [{"id": "T35", "text": "LMP1", "entity_type": "Protein", "start": 2, "end": 2}]}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "S17", "tokens": ["Several", "EBV", "transforming", "proteins", "have", "been", "studied", "in", "transgenic", "mouse", "models", ",", "however", ",", "only", "LMP1", "induces", "tumor", "development", "when", "expressed", "under", "the", "control", "of", "the", "Ig", "heavy", "chain", "promoter", "and", "enhancer", "[", "24-26", "]", "."], "sentence": "Several EBV transforming proteins have been studied in transgenic mouse models , however , only LMP1 induces tumor development when expressed under the control of the Ig heavy chain promoter and enhancer [ 24-26 ] .", "event_mentions": [{"id": "E21", "event_type": "Gene_expression", "trigger": {"text": "expressed", "start": 20, "end": 20}, "arguments": [{"entity_id": "T36", "text": "LMP1", "role": "Theme"}]}, {"id": "E22", "event_type": "Positive_regulation", "trigger": {"text": "under the control", "start": 21, "end": 23}, "arguments": [{"entity_id": "T73", "text": "expressed", "role": "Theme"}]}], "entity_mentions": [{"id": "T36", "text": "LMP1", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T73", "text": "expressed", "entity_type": "Gene_expression", "start": 20, "end": 20}, {"id": "T74", "text": "under the control", "entity_type": "Positive_regulation", "start": 21, "end": 23}]}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "S18", "tokens": ["The", "LMP1", "transgenic", "mice", "(", "IgLMP1", ")", "express", "LMP1", "in", "B", "lymphocytes", ",", "and", "in", "mice", "older", "than", "12", "mo", ",", "lymphoma", "develops", "with", "increased", "incidence", "(", "40", "%", "-50", "%", ")", "compared", "to", "wild-type", "control", "mice", "(", "11", "%", ")", ",", "suggesting", "that", "LMP1", "contributes", "to", "tumor", "development", "[", "26", "]", "."], "sentence": "The LMP1 transgenic mice ( IgLMP1 ) express LMP1 in B lymphocytes , and in mice older than 12 mo , lymphoma develops with increased incidence ( 40 % -50 % ) compared to wild-type control mice ( 11 % ) , suggesting that LMP1 contributes to tumor development [ 26 ] .", "event_mentions": [{"id": "E23", "event_type": "Gene_expression", "trigger": {"text": "express", "start": 7, "end": 7}, "arguments": [{"entity_id": "T38", "text": "LMP1", "role": "Theme"}]}], "entity_mentions": [{"id": "T37", "text": "LMP1", "entity_type": "Protein", "start": 1, "end": 1}, {"id": "T38", "text": "LMP1", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T39", "text": "LMP1", "entity_type": "Protein", "start": 44, "end": 44}, {"id": "T75", "text": "express", "entity_type": "Gene_expression", "start": 7, "end": 7}]}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "S19", "tokens": ["The", "LMP1", "lymphomas", "have", "rearranged", "Ig", "genes", "and", "have", "activated", "Akt", ",", "JNK", ",", "p38", ",", "and", "NFkappaB", ",", "with", "specific", "activation", "of", "the", "NFkappaB", "family", "member", "cRel", "[", "27", "]", "."], "sentence": "The LMP1 lymphomas have rearranged Ig genes and have activated Akt , JNK , p38 , and NFkappaB , with specific activation of the NFkappaB family member cRel [ 27 ] .", "event_mentions": [{"id": "E24", "event_type": "Positive_regulation", "trigger": {"text": "activated", "start": 9, "end": 9}, "arguments": [{"entity_id": "T41", "text": "Akt", "role": "Theme"}]}, {"id": "E25", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 21, "end": 21}, "arguments": [{"entity_id": "T42", "text": "cRel", "role": "Theme"}]}], "entity_mentions": [{"id": "T40", "text": "LMP1", "entity_type": "Protein", "start": 1, "end": 1}, {"id": "T41", "text": "Akt", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T42", "text": "cRel", "entity_type": "Protein", "start": 27, "end": 27}, {"id": "T76", "text": "activated", "entity_type": "Positive_regulation", "start": 9, "end": 9}, {"id": "T77", "text": "activation", "entity_type": "Positive_regulation", "start": 21, "end": 21}]}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "S20", "tokens": ["In", "this", "study", ",", "the", "LMP1", "transgenic", "lymphocytes", "and", "lymphomas", "were", "further", "characterized", "and", "their", "growth", "properties", "in", "vitro", "were", "determined", "."], "sentence": "In this study , the LMP1 transgenic lymphocytes and lymphomas were further characterized and their growth properties in vitro were determined .", "event_mentions": [], "entity_mentions": [{"id": "T43", "text": "LMP1", "entity_type": "Protein", "start": 5, "end": 5}]}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "", "tokens": ["To", "obtain", "pure", "populations", "of", "malignant", "lymphocytes", "and", "to", "enable", "more", "detailed", "biochemical", "analyses", ",", "examples", "of", "primary", "lymphomas", "were", "inoculated", "and", "passaged", "in", "SCID", "mice", "."], "sentence": "To obtain pure populations of malignant lymphocytes and to enable more detailed biochemical analyses , examples of primary lymphomas were inoculated and passaged in SCID mice .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "", "tokens": ["Interestingly", ",", "lymphoma", "development", "was", "restricted", "to", "B-1a", "lymphocytes", ",", "a", "self-replenishing", "population", "of", "cells", "that", "are", "prone", "to", "malignancy", "[", "28", ",", "29", "]", "."], "sentence": "Interestingly , lymphoma development was restricted to B-1a lymphocytes , a self-replenishing population of cells that are prone to malignancy [ 28 , 29 ] .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "S23", "tokens": ["LMP1", "transgenic", "lymphocytes", "had", "increased", "viability", "in", "vitro", "and", "viability", "was", "increased", "by", "the", "addition", "of", "IL4", "."], "sentence": "LMP1 transgenic lymphocytes had increased viability in vitro and viability was increased by the addition of IL4 .", "event_mentions": [], "entity_mentions": [{"id": "T44", "text": "LMP1", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T45", "text": "IL4", "entity_type": "Protein", "start": 16, "end": 16}]}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "S24", "tokens": ["In", "contrast", ",", "both", "LMP1", "-", "positive", "and", "-", "negative", "lymphoma", "cells", "were", "independent", "of", "IL4", "co", "-", "stimulation", "for", "survival", "and", "proliferation", "in", "vitro", "with", "a", "complete", "absence", "of", "activated", "Stat6", ",", "the", "IL4", "target", "."], "sentence": "In contrast , both LMP1 - positive and - negative lymphoma cells were independent of IL4 co - stimulation for survival and proliferation in vitro with a complete absence of activated Stat6 , the IL4 target .", "event_mentions": [{"id": "E26", "event_type": "Negative_regulation", "trigger": {"text": "absence", "start": 28, "end": 28}, "arguments": [{"entity_id": "T79", "text": "activated", "role": "Theme"}]}, {"id": "E27", "event_type": "Positive_regulation", "trigger": {"text": "activated", "start": 30, "end": 30}, "arguments": [{"entity_id": "T48", "text": "Stat6", "role": "Theme"}]}, {"id": "E28", "event_type": "Regulation", "trigger": {"text": "target", "start": 35, "end": 35}, "arguments": [{"entity_id": "T48", "text": "Stat6", "role": "Theme"}, {"entity_id": "T49", "text": "IL4", "role": "Cause"}]}], "entity_mentions": [{"id": "T46", "text": "LMP1", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T47", "text": "IL4", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T48", "text": "Stat6", "entity_type": "Protein", "start": 31, "end": 31}, {"id": "T49", "text": "IL4", "entity_type": "Protein", "start": 34, "end": 34}, {"id": "T78", "text": "absence", "entity_type": "Negative_regulation", "start": 28, "end": 28}, {"id": "T79", "text": "activated", "entity_type": "Positive_regulation", "start": 30, "end": 30}, {"id": "T80", "text": "target", "entity_type": "Regulation", "start": 35, "end": 35}]}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "S25", "tokens": ["The", "lymphomas", "were", "also", "distinguished", "by", "constitutive", "activation", "of", "Stat3", "and", "deregulation", "of", "the", "Rb", "cell", "cycle", "pathway", "."], "sentence": "The lymphomas were also distinguished by constitutive activation of Stat3 and deregulation of the Rb cell cycle pathway .", "event_mentions": [{"id": "E29", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 7, "end": 7}, "arguments": [{"entity_id": "T50", "text": "Stat3", "role": "Theme"}]}], "entity_mentions": [{"id": "T50", "text": "Stat3", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T51", "text": "Rb", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T81", "text": "activation", "entity_type": "Positive_regulation", "start": 7, "end": 7}]}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "S26", "tokens": ["Inhibition", "of", "the", "PI3K", "/", "Akt", ",", "NFkappaB", ",", "and", "Stat3", "signaling", "pathways", "blocked", "the", "enhanced", "growth", "of", "both", "LMP1", "transgenic", "and", "malignant", "lymphocytes", ",", "suggesting", "that", "these", "pathways", "are", "required", "for", "their", "growth", "and", "survival", "."], "sentence": "Inhibition of the PI3K / Akt , NFkappaB , and Stat3 signaling pathways blocked the enhanced growth of both LMP1 transgenic and malignant lymphocytes , suggesting that these pathways are required for their growth and survival .", "event_mentions": [], "entity_mentions": [{"id": "T52", "text": "Akt", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T53", "text": "Stat3", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T54", "text": "LMP1", "entity_type": "Protein", "start": 19, "end": 19}]}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "", "tokens": ["These", "appear", "to", "be", "the", "same", "targets", "that", "are", "deregulated", "in", "wild-type", "B-1a", "lymphomas", "that", "arise", "spontaneously", "through", "age", "predisposition", "."], "sentence": "These appear to be the same targets that are deregulated in wild-type B-1a lymphomas that arise spontaneously through age predisposition .", "event_mentions": [], "entity_mentions": [{"id": "T82", "text": "deregulated", "entity_type": "Regulation", "start": 9, "end": 9}]}
{"doc_id": "PMC-2065877-01-Introduction.txt", "sent_id": "S28", "tokens": ["This", "study", "reveals", "that", "LMP1", "promotes", "malignancy", "in", "cells", "with", "the", "inherent", "ability", "to", "proliferate", "and", "that", "the", "Akt", ",", "NFkappaB", ",", "and", "Stat3", "signaling", "pathways", "are", "required", "for", "its", "growth", "stimulatory", "effects", "."], "sentence": "This study reveals that LMP1 promotes malignancy in cells with the inherent ability to proliferate and that the Akt , NFkappaB , and Stat3 signaling pathways are required for its growth stimulatory effects .", "event_mentions": [], "entity_mentions": [{"id": "T55", "text": "LMP1", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T56", "text": "Akt", "entity_type": "Protein", "start": 18, "end": 18}, {"id": "T57", "text": "Stat3", "entity_type": "Protein", "start": 23, "end": 23}]}
